Replacement of E-cadherin by N-cadherin in the mammary gland leads to fibrocystic changes and tumor formation. - Wikidata - awgldk - TriplyDB

Replacement of E-cadherin by N-cadherin in the mammary gland leads to fibrocystic changes and tumor formation.

Replacement of E-cadherin by N-cadherin in the mammary gland leads to fibrocystic changes and tumor formation.

http://www.wikidata.org/entity/Q35683608

about

Homeostatic Signaling by Cell-Cell Junctions and Its Dysregulation during Cancer Progression Adhesion in mammary development: novel roles for E-cadherin in individual and collective cell migration Erythropoietin drives breast cancer progression by activation of its receptor EPOR GPR56 in cancer progression: current status and future perspective.Lobular breast cancer: molecular basis, mouse and cellular models.N-cadherin impedes proliferation of the multiple myeloma cancer stem cells.N-cadherin-mediated adhesion and signaling from development to disease: lessons from mice.Beyond E-cadherin: roles of other cadherin superfamily members in cancer.E-cadherin's role in development, tissue homeostasis and disease: Insights from mouse models: Tissue-specific inactivation of the adhesion protein E-cadherin in mice reveals its functions in health and disease.Silencing the YB-1 gene inhibits cell migration in gastric cancer in vitro.Bex2 is critical for migration and invasion in malignant glioma cells.Pancreatic Exocrine Tissue Architecture and Integrity are Maintained by E-cadherin During Postnatal Development

P2860

Q26768428-CCE672D1-BF2A-4E03-AEA6-530EDCA6BBDA Q28087050-0CFB9757-CBDA-4706-823D-61A04FD9AE7A Q33888764-4D35A23A-B04C-4F46-9C50-63FF9BB23F8D Q34269343-F58B147A-889E-43FE-BB39-81C8B3E296D8 Q35059856-1471B4CC-EF81-49DF-BC3D-E8CC9B43AE3A Q37419425-81ED3AC2-F4E7-4A65-AEE5-8D64BE21FC09 Q38088481-3DF5662C-C18A-4C7E-A999-A9B5E3175B37 Q38179961-B9BB760F-F92A-4522-82E2-01D09941C501 Q38275614-9FCD13B9-AED0-4452-9D92-D83FDC1432D9 Q39161502-ABCD26A2-24F2-44DF-8532-308DBE0DCB58 Q39294177-7F401E1E-F2FF-4CF6-9014-37F0474F13F7 Q58759701-294B14E3-74FE-487E-B968-23D2EC904C4E

P2860

Replacement of E-cadherin by N-cadherin in the mammary gland leads to fibrocystic changes and tumor formation.

http://www.wikidata.org/entity/Q35683608

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Replacement of E-cadherin by N ...... c changes and tumor formation.

@ast

Replacement of E-cadherin by N ...... c changes and tumor formation.

@en

type

label

Replacement of E-cadherin by N ...... c changes and tumor formation.

@ast

Replacement of E-cadherin by N ...... c changes and tumor formation.

@en

prefLabel

Replacement of E-cadherin by N ...... c changes and tumor formation.

@ast

Replacement of E-cadherin by N ...... c changes and tumor formation.

@en

P1433

Q35683608-2579D3C3-C64C-49CA-BCED-E3207A0A3BFC

P1476

Q35683608-42D6D072-12BB-4AA8-B042-8EEB6B8A7381

P2093

Q35683608-5F4949BE-8D7B-4745-96EF-59184408DD82

Q35683608-A2C5D0D5-E720-4225-AF08-99B65B8E2230

P2860

Q35683608-00ABAC01-B72E-471B-97C1-CF53BBB46C6F

Q35683608-06C0B05D-A339-46B0-BB67-E698DBA62016

Q35683608-152B8E86-6EC6-4DA0-80DD-FC68CF3A6F9B

Q35683608-1548DF55-C2DD-419C-8505-A1B38A75C135

Q35683608-199A9AB0-CA00-47E5-A0B3-A64E22706515

Q35683608-1AF15F2C-91B7-447A-858D-66CF70ACE113

Q35683608-1E740450-47DE-41A2-AF70-A89B7134B3C4

Q35683608-216E66D4-7DBE-4097-8D84-77E25BD8EBB1

Q35683608-24A58BDB-0390-4449-B5CE-848EDE24D8FE

Q35683608-272E6121-8B56-49AE-9EA4-9FBF583A477E

P2888

Q35683608-7F874171-2821-4973-8DBF-AC5DDFF4E091

P304

Q35683608-BDA12FE7-5F03-45E4-A293-7F9CB3248BE3

P31

Q35683608-1F27D2ED-6618-494D-AD29-4A421D01F262

P356

Q35683608-0B9D59A3-43D4-4DE6-B64A-0602BA53BEA1

P433

Q35683608-723B9452-E2E2-4E74-B11C-CB8A2BE710F4

P478

Q35683608-EC8ED95C-1E74-480B-BF2D-D8F442A99433

P50

Q35683608-28318F42-EFC1-46D4-88E6-3952FB37F7BD

P577

Q35683608-497497CD-04B8-465D-B1A9-DD6EF493E4C2

P5875

Q35683608-1D2E4CD4-E692-4917-8CE1-B2D440C82DED

P6179

Q35683608-75CE542E-AC40-48DB-80A5-0E42F1FA664C

P698

Q35683608-4826A803-0B5F-426E-9193-AB643EE4F593

P932

Q35683608-17B59EDC-C0D8-462B-B352-787907040607

P356

P1433

Breast Cancer Research

P1476

Replacement of E-cadherin by N ...... c changes and tumor formation.

@en

P2093

Ahmed M Kotb

http://www.w3.org/2001/XMLSchema#string

Andreas Hierholzer

http://www.w3.org/2001/XMLSchema#string

P2860

Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4

The molecular mechanism governing the oncogenic potential of SOX2 in breast cancer

The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species

The epithelial-mesenchymal transition: new insights in signaling, development, and disease

Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors

Generalized lacZ expression with the ROSA26 Cre reporter strain

Benign breast disorders

Developmental defects in mouse embryos lacking N-cadherin

Mammary epithelial cells are not able to undergo pregnancy-dependent differentiation in the absence of the helix-loop-helix inhibitor Id2

Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB

P2888

P304

R104

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/BCR3046

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-10-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51747876

http://www.w3.org/2001/XMLSchema#string

P6179

1022558366

http://www.w3.org/2001/XMLSchema#string

P698

22030022

http://www.w3.org/2001/XMLSchema#string

P932

3262217

http://www.w3.org/2001/XMLSchema#string